Lupin share news, announcements and annual reports
NSE: LUPINBSE: 500257Pharmaceuticals & BiotechnologyMid Cap
Lupin Limited · Face value ₹2 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Oct 1993 on BSE, Sep 2001 on NSE
Last close ₹2,011.00up ₹21.10 (1.06%)BSE ₹2,009.00
Share price at the NSE close on 30 Oct 2026. Previous close ₹1,989.90.
30 Oct: open ₹1,995.70, high ₹2,021.80, low ₹1,974.00
52-week range of traded prices to 30 Oct 2026
₹1,892.90Low, 23 Oct 2026₹2,529.50High, 16 Jul 2026
- Next results date: the board meets on 3 Nov 2026 to consider: financial results and other business matters. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹91,961 Cr105th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 16.63
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹558 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 15.11
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 4.10
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.90%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 27.9%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹558 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 30.7%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 28.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.26
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 7,59,66358.6% delivered
Lupin share news and announcements
2,113 announcements, routine notices left out, newest first. Page 32 of 43.
Sep 2014
Aug 2014
1 Aug · Disclosure of Voting Pattern - Clause 35A
Jul 2014
31 Jul · Legal
Exchange had sought clarification from Lupin Limited with respect to a news item captioned "Debt - free Lupin is Ready for Big Acquisition : CEO". The Company has clarified that "1) Comments on the news article: Ms. Vinita Gupta's comments about the Company being debt-free were based on the unaudited financial results for the quarter ended June 30, 2014, which were taken on record by the Board of Directors of Lupin Ltd. at its meeting held on July 30, 2014, conveyed to the Stock Exchanges and published in the newspapers. We wish to state that numbers quoted by Ms. Vinita in the news item forms part of the Press Release which was sent to the Stock Exchanges along with the said results. 2) Material impact of the news article on the Company: In its day-to-day operations, the Company actively explores opportunities for organic and inorganic growth including overseas acquisitions. The Company shall promptly inform the Exchanges once an acquisition is duly approved by the Board. 3) Relevant disclosure in this context: The news item states that the Company refused to comment. This is because, the Company does not comment on market rumours and speculations".30 Jul · Results
11 Jul · Meeting
Annual General Meeting of the Company will be held on July 30, 2014. Further, the Register of Members and Share Transfer Register will be closed from July 23, 2014 to July 30, 2014 (both days inclusive) for the purpose of Annual General Meeting and Final Dividend.
Jun 2014
May 2014
21 May · Legal
Exchange had sought clarification from Lupin Limited with respect to news item captioned "Venus ties up with Lupin to sell antibiotic drug in Oz.". The Company has clarified that "Lupin Limited has not received an official confirmation from Therapeutic Goods Administration (TGA) of Australia. We wish to further state that it is a routine transaction and does not have any material impact on the operations/profitability of the Company".7 May · Dividend
Board of Directors of the Company at its meeting held on May 07, 2014 have recommended final dividend @ 150% i.e. Rs. 3/- per equity share of the face value of Rs. 2/- each for the year ended March 31, 2014 subject to the approval of the shareholders at the ensuing Annual General Meeting. The Board of Directors had at their meeting held on February 3, 2014, declared and paid interim dividend of Rs.3/- per equity share of Rs.2/- each. Thus, the total dividend for the year ended March 31, 2014 would be Rs.6/- per equity share.
Apr 2014
Mar 2014
Feb 2014
3 Feb · Corporate action
Company has fixed Record Date as February 14, 2014 for the purpose of Interim dividend3 Feb · Dividend
Board of Directors of the Company at its meeting held on February 03, 2014 has declared an interim dividend @ 150% i.e. Rs. 3/- per fully paid-up equity share of Rs. 2/- each absorbing a sum of Rs.1345 million for the year ending March 31, 2014.
Jan 2014
24 Jan · Business
Allotment Committee of Directors at its meeting held on January 24, 2014 has allotted 92422 fully paid up equity shares of Rs. 2/- each. These shares have been allotted upon exercising of options granted to the employees under Stock option plans of the Company. In view of the above, the issued and paid up capital of the Company has been increased to Rs. 89,66,37,032 consisting 44,83,18,516 equity shares of Rs. 2/- each.24 Jan · Board meeting
Inter alia, to consider and take on record the unaudited financial results for the quarter and nine-month ended December 31, 2013 and the Board shall consider declaration of interim dividend, if any, for the year ending March 31, 2014.
Dec 2013
30 Dec · Disclosure
Company has granted 16700 options to the employee of its subsidiary Company, under Lupin Subsidiary Companies Employees Stock Option Plan 2011 on December 27, 2013, at the exercise price of Rs.907/-. Please note that one equity share of Rs.2/- each is covered by each option. The options issued are exercisable at the market price as defined in SEBI guidelines, in a phased manner after a minimum vesting period of 12 months but before the exercise period of 10 years from the date of grant.